FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16515711000001105: Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Feb 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57810801000001119 Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57810901000001113 Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose Is a Hydrocortisone 10% foam aerosol enema 14 dose true Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose Has AMP Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose Has specific active ingredient Hydrocortisone acetate true Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose Has dispensed dose form Foam true Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Mawdsley-Brooks & Company Ltd) 14 dose Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start